During the past decade, Memorial Hermann Hospital conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 38 clinical trials were completed, i.e. on average, 60.3% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 23 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Hermann Hospital" #1 sponsor was "The University of Texas Health Science Center, Houston" with 47 trials, followed by "Abbott Medical Devices" with 23 trials sponsored, "Pfizer" with 5 trials sponsored, "Cortice Biosciences, Inc." with 2 trials sponsored and "GlaxoSmithKline" with 2 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Hermann Hospital" #1 collaborator was "Medical University of South Carolina" with 5 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "Memorial Hermann Hospital" with 3 trials as a collaborator, "Neurological Emergencies Treatment Trials Network (NETT)" with 3 trials as a collaborator and "Abbott" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Hermann Hospital" are "Heart Failure" (7 trials), "Coronary Artery Disease" (6 trials), "Endotracheal Intubation" (4 trials), "Hypertension" (4 trials) and "Mitral Regurgitation" (4 trials). Many other conditions were trialed in "Memorial Hermann Hospital" in a lesser frequency.

Most popular intervention types in "Memorial Hermann Hospital" are "Drug" (51 trials), "Device" (50 trials), "Other" (23 trials), "Procedure" (12 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Bevacizumab" (2 trials), "CP-690,550" (2 trials), "Coronary PCI guided by Angiography" (2 trials) and "Coronary PCI guided by OCT" (2 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Hermann Hospital" are 122 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 31 active trials in "Memorial Hermann Hospital". 1 are not yet recruiting, 19 are recruiting, 9 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 70 completed trials in Memorial Hermann Hospital, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Hermann Hospital, 5 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 45 trials that are defined as “Not Applicable".